Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: A meta-analysis based on case-control studies

World Journal of Gastroenterology

Volumn 20, Issue 44, 2014, Pages 16765-16773

  Yang, Rong ^a   Zhang, Chong ^b   Malik, Armah ^b   Shen, Zhi Da ^c   Hu, Jian ^b   Wu, Yi He ^b  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Esophageal cancer; Meta analysis; Polymorphism; Xeroderma pigmentosum group D

Indexed keywords

XERODERMA PIGMENTOSUM GROUP D PROTEIN; ERCC2 PROTEIN, HUMAN;

ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; DNA POLYMORPHISM; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ETHNICITY; GENETIC MODEL; HUMAN; META ANALYSIS; PUBLISHING; CHI SQUARE DISTRIBUTION; ESOPHAGUS TUMOR; ETHNOLOGY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; ODDS RATIO; PHENOTYPE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ESOPHAGEAL NEOPLASMS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINEAR MODELS; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 84918787670     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i44.16765     Document Type: Article

References (36)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 DOI: 10.3322/caac.20107]
2. Islami F, Pourshams A, Nasrollahzadeh D, Kamangar F, Fahimi S, Shaken R, Abedi-Ardekani B, Merat S, Vahedi H, Semnani S, Abnet CC, Brennan P, Møller H, Saidi F, Dawsey SM, Malekzadeh R, Boffetta P. Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study. BMJ 2009; 338: b929 [PMID: 19325180 DOI: 10.1136/bmj.b929]
3. Engel LS, Chow WH, Vaughan TL, Gammon MD, Risch HA, Stanford JL, Schoenberg JB, Mayne ST, Dubrow R, Rotterdam H, West AB, Blaser M, Blot WJ, Gail MH, Fraumeni JF. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003; 95:1404-1413 [PMID: 13130116]
4. Islami F, Boffetta P, Ren JS, Pedoeim L, Khatib D, Kamangar F. High-temperature beverages and foods and esophageal cancer risk-a systematic review. Int J Cancer 2009; 125: 491-524 [PMID: 19415743 DOI: 10.1002/ijc.24445]
5. Zhang GH, Mai RQ, Huang B. Meta-analysis of ADH1B and ALDH2 polymorphisms and esophageal cancer risk in China. World J Gastroenterol 2010; 16: 6020-6025 [PMID: 21157980]
6. Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science 2001; 291: 1284-1289 [PMID: 11181991 DOI: 10.1126/science.1056154]
7. Hoeijmakers JH. Genome maintenance mechanisms are critical for preventing cancer as well as other aging-associated diseases. Mech Ageing Dev 2007; 128: 460-462 [PMID: 17588642 DOI: 50047-6374(07)00062-0]
8. Fan L, Fuss JO, Cheng QJ, Arvai AS, Hammel M, Roberts VA, Cooper PK, Tainer JA. XPD helicase structures and activities: insights into the cancer and aging phenotypes from XPD mutations. Cell 2008; 133: 789-800 [PMID: 18510924 DOI: 10.1016/j.cell.2008.04.030]
9. Shi Q, Wang LE, Bondy ML, Brewster A, Singletary SE, Wei Q. Reduced DNA repair of benzo [a] pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Carcino genesis 2004; 25: 1695-1700 [PMID: 15090466 DOI: 10.1093/carcin/bgh167]
10. Spitz MR, Wu X, Wang Y, Wang LE, Shete S, Amos CI, Guo Z, Lei L, Mohrenweiser H, Wei Q. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 2001; 61:1354-1357 [PMID: 11245433]
11. Hu JJ, Hall MC, Grossman L, Hedayati M, McCullough DL, Lohman K, Case LD. Deficient nucleotide excision repair capacity enhances human prostate cancer risk. Cancer Res 2004; 64:1197-1201 [PMID: 14871857]
12. Qin SY, Jiang HX, Lu DH, Zhou Y. Association of interleukin-10 polymorphisms with risk of irritable bowel syndrome: a meta-analysis. World J Gastroenterol 2013; 19: 9472-9480 [PMID: 24409078 DOI: 10.3748/wjg.v19.i48.9472]
13. Yan ZH, Fan Y, Wang XH, Mao Q, Deng GH, Wang YM. Relationship between HLA-DR gene polymorphisms and outcomes of hepatitis B viral infections: a meta-analysis. World J Gastroenterol 2012; 18: 3119-3128 [PMID: 22791948 DOI: 10.3748/wjg.v18.i24.3119]
14. Falvey JD, Bentley RW, Merriman TR, Hampton MB, Barclay ML, Gearry RB, Roberts RL. Macrophage migration inhibitory factor gene polymorphisms in inflammatory bowel disease: an association study in New Zealand Caucasians and meta-analysis. World J Gastroenterol 2013; 19: 6656-6664 [PMID: 24151396 DOI: 10.3748/wjg.v19.i39.6656]
15. Nie Y, Gu H, Gong J, Wang J, Gong D, Cong X, Chen X, Hu S. Methylenetetrahydrofolate reductase C677T polymorphism and congenital heart disease: a meta-analysis. Clin Chem Lab Med 2011; 49: 2101-2108 [PMID: 21793799 DOI: 10.1515/ CCLM.2011.673]
16. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634 [PMID: 9310563]
17. Liu G, Zhou W, Yeap BY, Su L, Wain JC, Poneros JM, Nishioka NS, Lynch TJ, Christiani DC. XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk. Carcinogenesis 2007; 28:1254-1258 [PMID: 17264068 DOI: bgm020]
18. Huang CG, Iv CD, Liu T, Liu Q, Feng JG, Lu XM. Polymorphisms of COMT and XPD and risk of esophageal squamous cell carcinoma in a population of Yili Prefecture, in Xinjiang, China. Biomarkers 2011; 16: 37-41 [PMID: 20979431 DOI: 10.3109/1354750X.2010.522732]
19. Tse D, Zhai R, Zhou W, Heist RS, Asomaning K, Su L, Lynch TJ, Wain JC, Christiani DC, Liu G. Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk. Cancer Causes Control 2008; 19: 1077-1083 [PMID: 18478337 DOI: 10.1007/ s10552-008-9171-4]
20. Huang CG, Liu T, Lv GD, Liu Q, Feng JG, Lu XM. Analysis of XPD genetic polymorphisms of esophageal squamous cell carcinoma in a population of Yili Prefecture, in Xinjiang, China. Mol Biol Rep 2012; 39: 709-714 [PMID: 21553048 DOI: 10.1007/s11033-011-0789-z]
21. Xing D, Qi J, Miao X, Lu W, Tan W, Lin D. Polymorphisms of DNA repair genes XRCC1 and XPD and their associations with risk of esophageal squamous cell carcinoma in a Chinese population. Int J Cancer 2002; 100: 600-605 [PMID: 12124811 DOI: 10.1002/ijc.10528]
22. Xing DY, Qi J, Tan W, Miao XP, Liang G, Yu GY, Lu WF, Zhou CN, Wu M, Lin DX. [Association of genetic polymorphisms in the DNA repair gene XPD with risk of lung and esophageal cancer in a Chinese population in Beijing]. Zhonghua Yi Xue Yi Chuan Xue Zazhi 2003; 20:35-38 [PMID: 12579497]
23. Yu HP, Wang XL, Sun X, Su YH, Wang YJ, Lu B, Shi LY, Xiong CL, Li YY, Li F, Xu SQ. Polymorphisms in the DNA repair gene XPD and susceptibility to esophageal squamous cell carcinoma. Cancer Genet Cytogenet 2004; 154:10-15 [PMID: 15381366 DOI: 10.1016/j.cancergencyto.2004.01.027]
24. Casson AG, Zheng Z, Evans SC, Veugelers PJ, Porter GA, Guernsey DL. Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma. Carcinogenesis 2005; 26: 1536-1541 [PMID: 15878910 DOI: bgi115]
25. Ye W, Kumar R, Bacova G, Lagergren J, Hemminki K, Nyrén O. The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden. Carcinogenesis 2006; 27: 1835-1841 [PMID: 16571649 DOI: bg1017]
26. Sobti RC, Singh J, Kaur P, Pachouri SS, Siddiqui EA, Bindra HS. XRCC1 codon 399 and ERCC2 codon 751 polymorphism, smoking, and drinking and risk of esophageal squamous cell carcinoma in a North Indian population. Cancer Genet Cytogenet 2007; 175: 91-97 [PMID: 17556064 DOI: SO165-4608(07)00002-7]
27. Doecke J, Zhao ZZ, Pandeya N, Sadeghi S, Stark M, Green AC, Hayward NK, Webb PM, Whiteman DC. Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma. Int J Cancer 2008; 123: 174-180 [PMID: 18386788 DOI: 10.1002/ijc.23410]
28. Ferguson HR, Wild CP, Anderson LA, Murphy SJ, Johnston BT, Murray LJ, Watson RG, McGuigan J, Reynolds JV, Hardie LJ. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett' s esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study. Cancer Epidemiol Biomarkers Prev 2008; 17: 736-739 [PMID: 18349297 DOI: 10.1158/1055-9965. EPI-07-2832]
29. Pan J, Lin J, Izzo JG, Liu Y, Xing J, Huang M, Ajani JA, Wu X. Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway. Carcinogenesis 2009; 30: 785-792 [PMID: 19270000 DOI: 10.1093/carcin/bgp058]
30. Zhai XD, Mo YN, Xue XQ, Zhao GS, Gao LB, Ai HW, Ye Y. XRCC1 codon 280 and ERCC2 codon 751 polymorphisms and risk of esophageal squamous cell carcinoma in a Chinese population. Bull Cancer 2009; 96: E61-E65 [PMID: 19762325 DOI: 10.1684/bdc.2009.0952]
31. Li RZ, Sun J. Association between XPD gene polymorphisms and esophageal squamous cell carcinoma. Mol Med Rep 2013; 7: 674-678 [PMID: 23229387 DOI: 10.3892/mmr.2012.1215]
32. Arizono K, Osada Y, Kuroda Y. DNA repair gene hOGG1 codon 326 and XRCC1 codon 399 polymorphisms and bladder cancer risk in a Japanese population. Jpn J Clin Oncol 2008; 38: 186-191 [PMID: 18272472 DOI: 10.1093/jjco/hym176]
33. Duan XL, Gong H, Zeng XT, Ni XB, Yan Y, Chen W, Liu GL. Association between XPD Asp312Asn polymorphism and esophageal cancer susceptibility: a meta-analysis. Asian Pac J Cancer Prev 2012; 13: 3299-3303 [PMID: 22994751]
34. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002; 4: 45-61 [PMID: 11882781 DOI: 10.109700125817-20 0203000-00002]
35. Ding DP, Ma WL, He XF, Zhang Y. XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies. Mol Biol Rep 2012; 39: 2533-2540 [PMID: 21667112 DOI: 10.1007/s11033-011-1005-x]
36. Yuan L, Cui D, Zhao EJ, Jia CZ, Wang LD, Lu WQ. XPD Lys751Gln polymorphism and esophageal cancer risk: a meta-analysis involving 2288 cases and 4096 controls. World J Gastroenterol 2011; 17: 2343-2348 [PMID: 21633601 DOI: 10.3748/wjg.v17.i18.2343]